New data from the KEYNOTE-756 phase 3 clinical trial show that adding the immunotherapy drug pembrolizumab to chemotherapy before and after surgery for breast cancer leads to better outcomes for patients regardless of their ...
Mar 19, 2024
0
1
Many cancer therapies, in addition to producing numerous side effects, fail to achieve complete tumor remission, partly due to the presence of cancer stem cells, which are difficult to eradicate. These cells can self-renew ...
Jan 31, 2024
0
0
A new research perspective titled "Genetic alterations in thyroid cancer mediating both resistance to BRAF inhibition and anaplastic transformation" has been published in Oncotarget.
Jan 29, 2024
0
0
It is only a few centimeters in size and can be held between two fingers, but hidden in the micro-channels carved inside it is a three-dimensional and highly faithful model of a biliary tract cancer called cholangiocarcinoma, ...
Jan 22, 2024
0
0
For patients with early-stage breast cancer, there is a 7% to 11% chance of relapse within five years after receiving initial treatment, and this rate can be higher for patients with more advanced stages of the cancer. While ...
Dec 29, 2023
0
67
Women 50 or older who de-escalated to less-frequent mammography three years after curative surgery for early-stage breast cancer had similar outcomes to women who received annual mammography, according to results from the ...
Dec 8, 2023
0
0
Almost all postmenopausal patients aged 50-–69 years with stage I hormone receptor (HR)-positive breast cancer and low scores on a common genetic test who opted out of adjuvant radiotherapy were disease free five years ...
Dec 7, 2023
0
0
For patients with early-stage breast cancer treated with neoadjuvant chemotherapy (NACT), Blacks have higher mortality risk than Whites, according to a study published online Nov. 22 in JAMA Network Open.
Nov 27, 2023
0
0
Using a routine chest X-ray image, an artificial intelligence (AI) tool can identify non-smokers who are at high risk for lung cancer, according to a study being presented next week at the annual meeting of the Radiological ...
Nov 22, 2023
0
0
Patients with ovarian cancer are 70% less likely to die three years after a multidisciplinary surgical approach is deployed, according to new research. The study from the Mater University Hospital on treating advanced ovarian ...
Oct 30, 2023
0
0
